Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Androgen receptor (AR) signaling plays a dual role in breast tissue and breast cancer.
• In normal breast tissue and ERα-positive luminal breast cancers, AR signaling is generally antiestrogenic and growth-inhibitory.
• However, in a subset of ERα-negative, AR-positive breast cancers with a molecular apocrine phenotype, AR signaling can promote tumor growth.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying the distinct gene expression programs induced by androgens.
• To understand how AR signaling elicits opposing proliferative responses in different breast cancer subtypes.
• To identify potential therapeutic strategies targeting AR in breast cancer treatment.

Main Methods:

• Analysis of gene expression patterns in different breast cancer phenotypes.
• Investigation of AR signaling pathways and their downstream effects.
• Comparative studies in ERα-positive and ERα-negative breast cancer models.

Main Results:

• Demonstrated that AR signaling can activate distinct molecular pathways depending on the ERα status of the breast cancer.
• Identified specific gene expression programs associated with AR-driven growth in ERα-negative cancers.
• Highlighted the differential impact of AR signaling on proliferation in various breast cancer contexts.

Conclusions:

• AR signaling has context-dependent effects on breast cancer proliferation, acting as a tumor suppressor in some and a promoter in others.
• Understanding these opposing roles is crucial for developing targeted AR-based therapies.
• Further research into AR signaling mechanisms may lead to novel treatment strategies for specific breast cancer subtypes.